...
【24h】

Circulating cathepsin B and D in pregnancy

机译:在怀孕中循环组织蛋白酶B和D.

获取原文
获取原文并翻译 | 示例

摘要

The purpose of this prospective study was to investigate the changes in the circulating levels of cathepsin B and D in pregnancy. We obtained longitudinal cathepsin B and D levels in 76 healthy pregnant women in the first and third trimesters and compared these levels with 20 non-pregnant controls. The plasma levels of soluble cathepsin B and D were measured using an enzyme-linked immunosorbent assay kit. The cathepsin D concentrations in the third trimester were significantly higher than that in the first trimester (p .001), and the cathepsin D levels in the first trimester were significantly lower than that in the non-pregnant controls (p = .002). However, there was no significant difference in the cathepsin B level throughout pregnancy compared to the non-pregnant controls. Our study is unique in evaluating the longitudinal changes in the cathepsin B and D levels in pregnancies without obstetric complications. The results implicate that changes in the levels of cathepsins might be essential in placentation. Therefore, molecular and genetic studies on cathepsin B and D are needed to understand the roles of these enzymes in pregnancy, thereby contributing to the understanding of placentation. Impact statement What is already known? Matrix metalloproteinases (MMP) have been widely studied, and their function is very important in the normal implantation process. The level of MMP-9 is known to increase throughout pregnancy, while the level of MMP-2 decreases in the first trimester. In addition to MMPs, other proteases are important for placental development; cathepsins B and D are two of the proteases that are involved in the normal placentation process. The function of cathepsin D is related to MMPs because this protease can activate MMPs either directly or indirectly. Nevertheless, the role of circulating cathepsins in pregnancy has not yet been fully elucidated. What do these results add? This study provides evidence, for the first time, that there are fluctuations of plasma cathepsin D level and there are no changes in the plasma cathepsin B level in a normal pregnancy. Moreover, we demonstrated that a cathepsin D level is significantly decreased in the first trimester compared to the non-pregnant controls, and that the level is markedly elevated in the third trimester.
机译:该前瞻性研究的目的是探讨妊娠中组织蛋白酶B和D循环水平的变化。我们在第一个和第三个三个月和第三个孕妇中获得了76名健康孕妇的纵向组织蛋白B和D水平,并将这些水平与20个非孕妇的控制相比。使用酶联免疫吸附试剂盒测量可溶性组织蛋白B和D的血浆水平。第三个三孕酮的组织蛋白酶D浓度明显高于前三个月(P& .001)中的浓度,并且第一个三孕酮中的组织蛋白酶D水平显着低于非妊娠对照中的水平(P = .002 )。然而,与非妊娠对照相比,妊娠的组织蛋白酶B水平没有显着差异。我们的研究是在没有产科并发症的怀孕中的妊娠中的纵向变化是独一无二的。结果暗示了组织蛋白酶水平的变化可能在置入中必不可少。因此,需要对组织蛋白酶B和D的分子和遗传研究来了解怀孕中这些酶的作用,从而有助于对置入的理解。影响声明已知的内容是什么?基质金属蛋白酶(MMP)已被广泛研究,其功能在正常植入过程中非常重要。已知MMP-9的水平在整个妊娠期间增加,而MMP-2的水平在妊娠中的含量降低。除了MMP之外,其他蛋白酶对于胎盘开发很重要;组织蛋白酶B和D是涉及正常置入过程的两种蛋白酶。组织蛋白酶D的功能与MMP相关,因为这种蛋白酶可以直接或间接激活MMP。然而,循环组织蛋白酶在怀孕中的作用尚未完全阐明。这些结果添加了什么?本研究首次提供了血浆组织蛋白D水平的波动,并且在正常妊娠中存在血浆组织蛋白B水平没有变化。此外,我们证明,与非妊娠对照相比,妊娠晚期的组织蛋白酶D水平显着下降,并且该水平在三个三个月的水平显着升高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号